Exodus Point Capital Management, LP Elevation Oncology, Inc. Transaction History

Exodus Point Capital Management, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 09, 2023	SELL	$0.65 - $1.56 $324,852 - $779,645	-499,773 Reduced 33.33%	999,546 $662,000
Q2 2023 Aug 10, 2023	BUY	$1.4 - $5.06 $2.1 Million - $7.59 Million	1,499,319 New	1,499,319 $2.28 Million

45.4M

700

27.6K

Ticker ELEV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,300,900
Market Cap $14M
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.